BioSpace News Archive

Business

Biocom California Selects New Chair for its Board of Directors

Biocom California today announced that it has named a new board chair and chair elect. Timothy Scott, CEO of TEGA Therapeutics is the new chair, and Sabrina Martucci Johnson, CEO of Daré Bioscience, is the chair elect.

January 10, 2022
·
4 min read
Business

Cardea Bio announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications

Today, Cardea Bio, Inc. announced a collaboration agreement with Siemens Healthineers’ Center for Innovation in Diagnostics (CID) to assess feasibility of developing real-time biosensor applications using Cardea’s BPU™ (Biosignal Processing Unit) Platform.

January 10, 2022
·
2 min read
Healthcare Education Solutions Market Size, Share, Industry Analysis By End-Use, By Application, By Delivery, By Providers, and Region Forecast to 2028

Factors that negatively affected growth in the historic period were low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes.

January 10, 2022
·
7 min read
Healthcare Supply Chain Management Market Size, Share, Analysis By Product, By Mode of Delivery And Forecasts to 2028

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

January 10, 2022
·
6 min read
BioMidwest

Life Spine to Present at 40th Annual J.P. Morgan Healthcare Conference

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company will present at the 40th Annual J.P. Morgan Healthcare Conference.

January 10, 2022
·
1 min read
Business

BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to Study Mecbotamab Vedotin (BA3011) and Ozuriftamab Vedotin (BA3021) in Combination with Opdivo® (nivolumab) for Treatment of Solid Tumors

BioAtla, Inc. (Nasdaq: BCAB), today announced that it has entered into a clinical collaboration with Bristol Myers Squibb (NYSE: BMY) to investigate BioAtla’s two lead CAB-ADC candidates, BA3011 and BA3021, in combination with Bristol Myers Squibb’s anti-PD-1 therapy Opdivo® (nivolumab).

January 10, 2022
·
7 min read
Business

STRATA Skin Sciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, reported preliminary, unaudited fourth quarter 2021 financial results.

January 10, 2022
·
4 min read
Business

Illumina collaborates with Nashville Biosciences to accelerate medicines development

Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource.

January 10, 2022
·
4 min read
Business

Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), today announced nomination of the first targeted alpha therapy (TAT) candidate under the Company’s collaboration agreement with AstraZeneca (LSE/STO/Nasdaq: AZN).

January 10, 2022
·
5 min read
Deals

CNS Pharmaceuticals Announces Closing of $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

CNS Pharmaceuticals, Inc. announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules of 12,105,264 shares of common stock.

January 10, 2022
·
5 min read